P Palthera

Education

How Peptides Are Studied

An introduction to common laboratory approaches used to evaluate peptide behaviour.

Abstract reference visual for Methodology.
Methodology
Category
education
Level
Foundation
Reading time
6 min
References
2

Section

Model Selection

Researchers select , , or animal models based on the specific question being examined. Each model has limitations that affect interpretation.

Section

Measured Signals

Studies may measure binding, , signalling markers, or cellular morphology. These observations do not establish consumer or therapeutic use.

Section

Documentation

Experimental records commonly include compound source, batch, concentration, exposure window, environmental controls, and conditions so observations can be reviewed in context.

References

Each article cites a minimum of two peer-reviewed sources. Citations record model type and reported sample size where the source provides them. Findings are model-specific and must not be extrapolated to therapeutic use.

Peptide-based drug discovery: Current status and recent advances

2023

Sharma K et al. · Drug Discovery Today

Model
Narrative review
Sample
N/A (review)

Surveyed contemporary peptide discovery workflows, including library design, screening, and lead optimisation methodology.

PMID 36481586DOI 10.1016/j.drudis.2022.103464

The Road to Reproducibility in Animal Research

2016

Jilka RL et al. · Journal of Bone and Mineral Research

Model
Narrative review
Sample
N/A (review)

Discussed the reproducibility gap in animal research and argued for stricter methodological reporting (e.g., ARRIVE-style guidance).

PMID 27255286DOI 10.1002/jbmr.2881

Peptides discussed

Profiles referenced in this article

View library →

CJC-1295

Hormone Analogues

Synthetic GHRH analogue (with or without DAC)

CJC-1295 is a synthetic GHRH analogue investigated in early-phase human pharmacology studies and in GHRH-knockout rodent models. Published primary human research is limited to small Phase I/II pharmacokinetic and pharmacodynamic trials.

Phase I/II human pharmacology and rodent literature

View research profile

Semax

Signalling Peptides

Synthetic ACTH(4–7)-derived heptapeptide analogue

Semax is a synthetic heptapeptide derived from ACTH(4–7), most extensively characterised in rodent models of cerebral ischaemia and in vitro neurobiology assays. Approved in the Russian Federation as a research and clinical compound; not approved for human therapeutic use in the United States, United Kingdom, or European Union.

Rodent neurobiology and in vitro literature

View research profile

Selank

Synthetic Peptides

Synthetic tuftsin-derived heptapeptide

Selank is a synthetic heptapeptide analogue of the immunopeptide tuftsin, primarily characterised in rodent behavioural models (anxiety, stress, withdrawal) and in vitro neurochemistry assays. Regulatory status varies — research-use context only on this platform.

Rodent behavioural and in vitro neurochemistry literature

View research profile